A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previous...

per Trnĕný, Marek, Verhoef, Gregor, Dyer, Martin JS, Ben Yehuda, Dina, Patti, Caterina, Canales, Miguel, Lopez, Andrés, Awan, Farrukh T, Montgomery, Paul G, Janikova, Andrea, Barbui, Anna M, Sulek, Kazimierz, Terol, Maria J, Radford, John, Guidetti, Anna, Di Nicola, Massimo, Siraudin, Laure, Hatteville, Laurence, Schwab, Sandrine, Oprea, Corina, Gianni, Alessandro M
Publicat a Haematologica (2018)